Management of Warfarin Toxicity in Outpatients
Assessment and Management
- The American College of Cardiology recommends reducing or omitting the next warfarin dose and resuming at a lower dose when the INR approaches the therapeutic range for patients with INR above therapeutic range but <5.0 and no significant bleeding 1
- The American Geriatrics Society recommends rechecking INR within 1-2 days to monitor response for patients with INR above therapeutic range but <5.0 and no significant bleeding 2
- For patients with INR 5.0-9.0 and no bleeding, the American College of Cardiology recommends omitting the next 1-2 doses of warfarin and reinstating warfarin at a lower dose when INR falls into therapeutic range 1, 3
- For patients at increased risk of bleeding with INR 5.0-9.0, the American College of Cardiology recommends omitting the next dose of warfarin and administering oral vitamin K₁ 1-2.5 mg 1, 3
- The American College of Cardiology recommends administering oral vitamin K₁ 3-5 mg for patients with INR >9.0 and no significant bleeding 1, 3
- For urgent reversal needed, the American College of Cardiology recommends administering oral vitamin K₁ 2-5 mg and expecting INR reduction within 24 hours 1
Risk Factors and Monitoring
- The American College of Cardiology identifies age >65 years, history of stroke or gastrointestinal bleeding, comorbid conditions, and concomitant use of medications that affect platelet function as risk factors for warfarin-associated bleeding 1, 2, 4
- The American Geriatrics Society recommends monitoring INR daily until stable, then 2-3 times weekly for 1-2 weeks, and then weekly for 1 month after toxicity management 2
- More frequent monitoring is required during changes in medications, diet, or illness, according to the American Geriatrics Society 2
Long-term Management
- The American College of Cardiology recommends considering reduced target INR of 2.0-2.5 for mechanical heart valves and 1.5-2.0 for atrial fibrillation after a bleeding episode 4
- For some atrial fibrillation patients, the American College of Cardiology recommends considering aspirin as an alternative 4